March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) :
- ALA-101 AND ONCARLYTICS COLLABORATION UPDATE
- IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
- PARTNERSHIP TO COMBINE ALA‐101 AND ONCARLYTICS HAS ENDED
- NO FINANCIAL IMPACT FROM CESSATION OF COLLABORATION FOR AROVELLA
- COLLABORATION WILL BE TERMINATED WITH IMMEDIATE EFFECT
- TERMINATION WILL NOT IMPACT CO'S DEVELOPMENT OF ALA‐101 FOR CD19‐POSITIVE BLOOD CANCERS
(([email protected];;))
- Forums
- ASX - By Stock
- News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) : ALA-101...
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $431.8M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.6¢ | $1.037M | 17.94M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1882949 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 399643 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1882949 | 0.058 |
11 | 3369960 | 0.057 |
27 | 4811046 | 0.056 |
28 | 4598665 | 0.055 |
9 | 305001 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 399643 | 3 |
0.060 | 2631845 | 18 |
0.061 | 773907 | 4 |
0.062 | 2227969 | 6 |
0.063 | 243179 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online